Lifeworks Advisors, LLC Eli Lilly & CO Transaction History

Lifeworks Advisors, LLC

$496 Million
Q3 2024

A detailed history of Lifeworks Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lifeworks Advisors, LLC holds 7,179 shares of LLY stock, worth $5.7 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares

7,179

Previous 7,480 4.02%

Holding current value

$5.7 Million

Previous $6.77 Million 6.08%

% of portfolio

1.28%

Previous 1.93%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$772.14 - $960.02 $232,414 - $288,966	-301 Reduced 4.02%	7,179 $6.36 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $129,751 - $162,718	179 Added 2.45%	7,480 $6.77 Million
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $213,784 - $286,013	361 Added 5.2%	7,301 $5.68 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $627,602 - $739,860	-1,195 Reduced 14.69%	6,940 $4.05 Million
Q3 2023 Nov 01, 2023	SELL	$434.7 - $599.3 $811,150 - $1.12 Million	-1,866 Reduced 18.66%	8,135 $4.37 Million
Q2 2023 Aug 02, 2023	BUY	$350.74 - $468.98 $23,499 - $31,421	67 Added 0.67%	10,001 $4.69 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $22,054 - $25,902	71 Added 0.72%	9,934 $3.41 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $111,256 - $129,635	346 Added 3.64%	9,863 $3.61 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $98,727 - $112,510	-333 Reduced 3.38%	9,517 $3.45 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $176,436 - $207,161	-633 Reduced 6.04%	9,850 $3.19 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $1.18 Million - $1.47 Million	5,023 Added 92.0%	10,483 $3 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $1.23 Million - $1.52 Million	5,460 New	5,460 $1.51 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lifeworks Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lifeworks Advisors, LLC with notifications on news.

Account

Lifeworks Advisors, LLC Eli Lilly & CO Transaction History